Bridgeway Capital Management’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-173,000
Closed -$190K – 1269
2026
Q2
$190K Hold
173,000
– – ﹤0.01% 1067
2026
Q1
$301K Hold
173,000
– – 0.01% 934
2025
Q4
$301K Buy
+173,000
New +$381K 0.01% 934
2014
Q2
– Sell
-625
Closed -$100K – 1445
2014
Q1
$100K Hold
625
– – ﹤0.01% 1386
2013
Q4
$87K Hold
625
– – ﹤0.01% 1361
2013
Q3
$62K Buy
+625
New +$52.4K ﹤0.01% 1403

Other funds holding INO

Bridgeway Capital Management's INO Position: Q3 2026 in Review

Bridgeway Capital Management sold out of Inovio Pharmaceuticals (INO) in Q3 2026, closing a stake of 173,000 shares — an estimated $190K sold.

Bridgeway Capital Management first reported a position in INO in Q3 2013 and held it in 6 quarters. The position peaked at $301K in Q1 2026. 110 funds tracked by Wall St. Rank hold INO as of Q3 2026.

  • Bridgeway Capital Management reported no remaining Inovio Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Bridgeway Capital Management sold 173,000 Inovio Pharmaceuticals shares in Q3 2026, an estimated $190K.
  • Bridgeway Capital Management first reported a position in Inovio Pharmaceuticals in Q3 2013 and held it in 6 quarters.
  • Bridgeway Capital Management's Inovio Pharmaceuticals position peaked at $301K in Q1 2026.
  • 110 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2026.

Based on Bridgeway Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.